Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-05 Option Award | 2024-06-07 5:05 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Ball Titus B. Principal Accounting Officer | 39,767 | $0 | 63,245 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:04 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wu Xiaobin President, COO & GM China | 730,795 | $0 | 1,762,600 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:03 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wang Lai Global Head of R&D | 487,188 | $0 | 2,145,403 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:03 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Lee Chan Henry SVP, General Counsel | 282,880 | $0 | 454,194 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:02 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Dugan Margaret Director | 50,492 | $0 | 80,106 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:01 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 50,492 | $0 | 50,492 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:00 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | HOOPER ANTHONY C Director | 50,492 | $0 | 87,906 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:58 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | OYLER JOHN Chief Executive Officer | 1,414,439 | $0 | 48,926,756 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:58 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 50,492 | $0 | 2,752,615 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:57 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Riva Alessandro Director | 50,492 | $0 | 80,106 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:56 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 519,649 | $0 | 11,165,677 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:55 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Sanders Corazon (Corsee) D. Director | 50,492 | $0 | 80,392 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:54 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Wang Julia Aijun Chief Financial Officer | 392,899 | $0 | 712,985 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:31 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | Yi Qingqing Director | 50,492 | $0 | 80,106 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:03 pm | N/A 2034-06-04 | BeiGene Ltd. | BGNE | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 169,286 | $0 | 10,852,438 (Indirect) | View |
Ownership | 2024-03-26 5:26 pm | N/A N/A | BeiGene Ltd. | BGNE | Ball Titus B. Principal Accounting Officer | 0 | $0 | 38,155 (Direct) | View |
| 2024-03-11 Gift | 2024-03-13 5:04 pm | N/A N/A | BeiGene Ltd. | BGNE | Glazer Donald W. Director | 82,020 | $0 | 2,702,123 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 5:24 pm | N/A 2034-02-28 | BeiGene Ltd. | BGNE | BRANDICOURT OLIVIER Director | 27,794 | $0 | 27,794 (Direct) | View |
| 2023-11-30 Other | 2023-12-04 5:44 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 172,372 | $0 | 10,818,400 (Indirect) | View |
| 2023-11-30 Gift | 2023-12-04 5:44 pm | N/A N/A | BeiGene Ltd. | BGNE | Wang Xiaodong Chair, Scientific Advisory Brd | 71,890 | $0 | 10,818,400 (Direct) | View |